Evidence map›Paper›PMID 35116709›Full record

ArticleTranslational cancer research2021

Long non-coding RNA ZNF674-AS1 regulates miR-23a/E-cadherin axis to suppress the migration and invasion of non-small cell lung cancer cells.

Jie Wang, Sha Liu, Tao Pan, Mingkun Wang, Liang Li, Xiangqian Weng, Panhong Jia, Qi Li, Xiangdong Zhou

Open access · diamondAbstract read
In one paragraph

Article in Translational cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jie Wang *Nanjing Medical University, Nanjing, China.
Sha Liu *Department of Radiotherapy, the First Affiliated Hospital of Hainan Medical University, Haikou, China.
Tao Pan *Department of Radiotherapy, the First Affiliated Hospital of Hainan Medical University, Haikou, China.
Mingkun WangDepartment of Radiotherapy, the First Affiliated Hospital of Hainan Medical University, Haikou, China.
Liang LiDepartment of Respiratory Diseases, the First Affiliated Hospital of Hainan Medical University, Haikou, China.
Xiangqian WengDepartment of Radiotherapy, the First Affiliated Hospital of Hainan Medical University, Haikou, China.
Panhong JiaHainan Medical University, Haikou, China.
Qi LiDepartment of Respiratory Diseases, the First Affiliated Hospital of Hainan Medical University, Haikou, China.
Xiangdong ZhouNanjing Medical University, Nanjing, China.
Hainan Medical University · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-small cell lung cancer (NSCLC) is one of the most common malignant tumors. The prognosis of patients with advanced NSCLC is poor due to metastasis. In recent years, the role of long non-coding RNAs (lncRNAs), a class of non-coding RNA molecules, in NSCLC has become an increasingly popular focus of studies. This study aimed to investigate the effects of ZNF674-AS1 and microRNA (miR)-23a on the migration and invasion abilities of NSCLC cells

methodsThe expression levels of ZNF674-AS1 and miR-23a in NSCLC tissues and cells were detected by quantitative real-time polymerase chain reaction (qRT-PCR). Scratch test and transwell test were used to detect the effects of ZNF674-AS1 and miR-23a on the migration and invasion of NSCLC cells. The luciferase reporter gene experiment was used to verify miRNA targets. Western blot experiments were used to analyze protein expression.

resultsZNF674-AS1 was downregulated in NSCLC tissues and cells, and inhibited the migration and invasion of NSCLC cells

conclusionsZNF674-AS1 inhibits the migration and invasion of NSCLC cells by regulating a miR-23a/E-cadherin axis. ZNF674-AS1 and miR-23a could become potential therapeutic targets for NSCLC.

Indexed as

E-cadherinlong non-coding RNA (lncRNA)miR-23aNon-small cell lung cancer (NSCLC)ZNF674-AS1

Identifiers

PMID35116709
PMCPMC8798196
OpenAlexW3198949249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.